BRCA1-positive breast cancers in young women from Poland
- 16 March 2006
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 99 (1) , 71-76
- https://doi.org/10.1007/s10549-006-9182-3
Abstract
We identified 4316 unselected incident cases of early-onset breast cancers (<51 ears of age at diagnosis) in 18 Polish hospitals between 1996 and 2003. We were able to obtain a blood sample for DNA analysis from 3472 of these (80.4%). All cases were tested for the presence of three founder mutations in BRCA1. The proportion of cases with a BRCA1 mutation was 5.7%. The hereditary proportions were higher than this for women with breast cancer diagnosed before age 40 (9%), for women with cancer of medullary or atypical medullary histology (28%), for those with bilateral cancer (29%) or with a family history of breast or ovarian cancer (13%). It is reasonable to offer genetic testing to women with early-onset breast cancer in Poland.Keywords
This publication has 12 references indexed in Scilit:
- Breast cancer predisposing alleles in PolandBreast Cancer Research and Treatment, 2005
- The Pathology of Hereditary Breast CancerHereditary Cancer in Clinical Practice, 2004
- A high proportion of founder BRCA1 mutations in Polish breast cancer familiesInternational Journal of Cancer, 2004
- Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1‐related breast carcinomaCancer, 2003
- Founder Mutations in the BRCA1 Gene in Polish Families with Breast-Ovarian CancerAmerican Journal of Human Genetics, 2000
- Multifactorial Analysis of Differences Between Sporadic Breast Cancers and Cancers Involving BRCA1 and BRCA2 MutationsJNCI Journal of the National Cancer Institute, 1998
- Low frequency of lymph-node metastasis in BRCA1-associated breast cancerThe Lancet, 1998
- Brca2 hereditary breast cancer pathophenotypeBreast Cancer Research and Treatment, 1997
- Tumour biological features of BRCA1-induced breast and ovarian cancerEuropean Journal Of Cancer, 1997
- In-situ breast cancer and BRCA 1The Lancet, 1996